Phase II Study on Dose Escalating Schedule of Paclitaxel Concurrent with Radiotherapy in Treating Patients with Locally Advanced Non-small Cell Lung Cancer |
Cui, Lin
(Department of Oncology, Taizhou Second People's Hospital, the Affiliated Hospital of Yangzhou University)
Liu, Xing-Xiang (Department of Oncology, Taizhou Second People's Hospital, the Affiliated Hospital of Yangzhou University) Jiang, Yong (Department of Oncology, Taizhou Second People's Hospital, the Affiliated Hospital of Yangzhou University) Liu, Jian-Jun (Department of Oncology, Taizhou Second People's Hospital, the Affiliated Hospital of Yangzhou University) Zhou, Xiang-Rong (Department of Oncology, Taizhou Second People's Hospital, the Affiliated Hospital of Yangzhou University) He, Xue-Jun (Department of Oncology, Taizhou Second People's Hospital, the Affiliated Hospital of Yangzhou University) Chen, Jue (Department of Oncology, Taizhou Second People's Hospital, the Affiliated Hospital of Yangzhou University) Huang, Xin-En (Department of Chemotherapy, Affiliated Jiangsu Cancer Hospital of Nanjing Medical University & Jiangsu Institute of Cancer Research) |
1 | Liu YC, Zhou SB, Gao F, et al (2013). Chemotherapy and late course three dimensional conformal radiotherapy for treatment of patients with stage III non- small cell lung cancer. Asian Pac J Cancer Prev, 14, 2663-5. DOI ScienceOn |
2 | Lu B, Ouyang W, Yi F, et al (2004). Concurrent chemotherapy and radiotherapy for advanced non-small-cell lung cancer. Chin J Rad Oncol, 13, 177-9. |
3 | Lu YY, Huang XE, Cao J, et al (2013). Phase II study on Javanica oil emulsion injection () combined with chemotherapy in treating patients with advanced lung adenocarcinoma. Asian Pac J Cancer Prev, 14, 4791-4. DOI ScienceOn |
4 | Ourari-Dhahri B, Ben Slima H, Ben Amar J, et al (2012). Management of non small cell lung cancer. Tunis Med, 90, 847-51. |
5 | Salama JK, Vokes EE (2013). New radiotherapy and Chemoradiotherapy approaches for non-small-cell lung cancer. J Clin Oncol, 31, 1029-38. DOI ScienceOn |
6 | Sculier JP (2013). Nonsmall cell lung cancer. Eur Respir Rev, 22, 33-6. DOI ScienceOn |
7 | Solomon B, Ball DL, Richardson G, et al (2003). Phase I/II study of concurrent twice-weekly paclitaxel and weekly cisplatin with radiation therapy for stage III non-small cell lung cancer. Lung Cancer, 41, 353-61. DOI ScienceOn |
8 | Trotti A, Byhardt R, Stetz J, et al (2000). Common toxicity criteria:version 2.0. an improved reference for grading the acute effects of cancer treatment: impact on chemotherapy. Int J Radiat Oncol Biol Phys, 47, 13-47. DOI ScienceOn |
9 | Curran WJ Jr, Paulus R, Langer CJ, et al (2011). Sequential vs. concurrent chemoradiation for stage III non-small cell lung cancer: randomized phase III trial RTOG 9410. J Natl Cancer Inst, 103, 1452-60. DOI ScienceOn |
10 | Al-Hashimi MM, Wang XJ (2014). Trend analysis of lung cancer incidence rates in ninawa province, iraq, from 2000 to 2010 - decrease and recent stability. Asian Pac J Cancer Prev, 15, 385-90. DOI ScienceOn |
11 | Andoh H, McNulty NJ, Lewis PJ (2013). Improving accuracy in reporting CT scans of oncology patients: assessing the effect of education and feedback interventions on the application of the Response Evaluation Criteria in Solid Tumors (RECIST) criteria. Acad Radiol, 20, 351-7. DOI ScienceOn |
12 | Byhardt RW, Scott C, Sause WT, Emami B, et al (1998). Response, toxicity, failure patterns, and survival in five Radiation Therapy Oncology Group (RTOG) trials of sequential and/or concurrent chemotherapy and radiotherapy for locally advanced non-small-cell carcinoma of the lung. Int J Radiat Oncol Biol Phys, 42, 469-78. DOI ScienceOn |
13 | Wu Y, Liao M, Jiang G, et al (2002). Consensus on the diagnosis and treatment of local advanced non-small cell lung cancer. Chin J Oncol, 24, 576. |
14 | Yin HT, Tian QZ, Guan L, et al (2013). In vitro and in vivo evaluation of the antitumor efficiency of resveratrol against lung cancer. Asian Pac J Cancer Prev, 14, 1703-6. DOI ScienceOn |
15 | Vokes E E, Herndon J E 2nd, Crawford J, et al (2002). Randomized phase II study of cisplatin with gemcitabine or paclitaxel or vinorelbine as induction chemotherapy followed by concomitant Chemoradiotherapy for stage M b non-small cell lung cancer: cancer and leukemia group B study 9431. J Clin Oncol, 20, 4191-8. DOI ScienceOn |
16 | Wang X, Wang , Lu J, et al (2006). Concurrent paclitaxel or/and carboplatin with radiotherapy for stageIIInon-small cell lung cancer. Chin J Rad Oncol, 15, 270-4. |
17 | Zhou JN, Huang XE, Ye Z, et al (2009). Weekly paclitaxel/ docetaxel combined with a platinum in the treatment of advanced non-small cell lung cancer: a study on efficacy, safety and pre-medication. Asian Pac J Cancer Prev, 10, 1147-50. |
18 | Zhou X, Cui L, Liu J (2009). Sequential and Concurrent Chemo- Radiotherapy for Middle and Advanced Stage Non-Small Cell Lung Cancer. J Basic Clin Oncol, 22, 132-3. |
19 | Lu J, Wang L, Zhou Z, et al (2004). Phase II study on concomitant paclitaxel and radiotherapy for loc ally advanced non-small cell lung cancer[J]. Chin J Rad Oncol, 13, 89-92. |
20 | Lara PN Jr, Goldberg Z, Davies A, et a1 (2002). Concurrent chemoradiation strategies in the management of unresectable stage III non-small-cell lung cancer. Clin Lung Cancer, 3, 42-8. DOI ScienceOn |
21 | Demirci E1, Daloglu F, Gundogdu C, et al (2013). Incidence and clinicopathologic features of primary lung cancer: a North-Eastern Anatolia region study in Turkey (2006-2012). Asian Pac J Cancer Prev, 14, 1989-93. DOI ScienceOn |
22 | Chen LK, Liang Y, Yang QY, et al (2012). Triplet platinum-based combination sequential chemotherapy improves survival outcome and quality of life of advanced non-small cell lung cancer patients. Asian Pac J Cancer Prev, 13, 1863-7. DOI ScienceOn |
23 | Chen Y, Pandya K, Keng PP, et al (2001). Schedule-dependent pulsed paclitaxel radio-sensitization for thoracic malignancy. Am J Clin Oncol, 24, 432-7. DOI ScienceOn |
24 | Cufer T, Ovcaricek T, O'Brien ME (2013). Systemic therapy of advanced non-small cell lung cancer: major-developments of the last 5-years. Eur J Cancer, 49, 1216-25. DOI ScienceOn |
25 | Field JK, Oudkerk M, Pedersen JH, et al (2013). Prospects for population screening and diagnosis of lung cancer. Lancet, 382, 732-41. DOI ScienceOn |
26 | Fournel P, Robinet G, Thomas P, et al (2005). Randomized phase III trial of sequential Chemoradiotherapy compared with concurrent Chemoradiotherapy in locally advanced non-small-cell lung cancer: Groupe Lyon-Saint-Etienned Oncologie Thoracique-Groupe Francais de Pneumo- Cancerologie NPC 95-01 Study. J Clin Oncol, 23, 5910-7. DOI ScienceOn |
27 | Jemal A, Siegel R, Ward E, et al (2010). Cancer statistics, 2010. CA Cancer J Clin, 60, 277-300. DOI |
28 | Jiang Y, Cui L, Wu X, et al (2012). Radiosensitizing Effect of Weekly-dose Paclitaxel on Locally Advanced Esophageal Carcinoma. J Basic Clin Oncol, 6, 489-92. |